![[Feedback]](/icons/banner/feedbackACT.gif){kind=icon}
![[For Subscribers]](/icons/banner/subscriberACT.gif){kind=icon}
![[Archive]](/icons/banner/archiveACT.gif){kind=icon}
![[Search]](/icons/banner/searchACT.gif){kind=icon}
![[Contents]](/icons/banner/tocACT.gif){kind=icon}
|
|
|
|
|
||
Divisions of
*
Clinical Mass Spectrometry and
Gastroenterology and Nutrition,
**
Department of Pediatrics, Children’s Hospital Medical Center and College of Pharmacy, University of Cincinnati College of Medicine, Cincinnati, Ohio 45229 and
Department of Nutrition, University of Surrey, Guildford, U.K.
3To whom correspondence should be addressed at Clinical Mass Spectrometry, Children’s Hospital Medical Center, 3333 Burnet Avenue, Cincinnati, OH 45229. E-mail: SETCK0{at}chmcc.org
The pharmacokinetic behavior of naturally occurring isoflavones has been determined for the first time in healthy adults. We compared plasma kinetics of pure daidzein, genistein and their ß-glycosides administered as a single-bolus dose to 19 healthy women. This study demonstrates differences in the pharmacokinetics of isoflavone glycosides compared with their respective ß-glycosides. Although all isoflavones are efficiently absorbed from the intestinal tract, there are striking differences in the fate of aglycones and ß-glycosides. Mean time to attain peak plasma concentrations (tmax) for the aglycones genistein and daidzein was 5.2 and 6.6 h, respectively, whereas for the corresponding ß-glycosides, the tmax was delayed to 9.3 and 9.0 h, respectively, consistent with the residence time needed for hydrolytic cleavage of the glycoside moiety for bioavailability. The apparent volume of distribution of isoflavones confirms extensive tissue distribution after absorption. Plasma genistein concentrations are consistently higher than daidzein when equal amounts of the two isoflavones are administered, and this is accounted for by the more extensive distribution of daidzein (236 L) compared with genistein (161 L). The systemic bioavailability of genistein [mean AUC = 4.54 µg/(mL · h)] is much greater than that of daidzein [mean AUC = 2.94 µg/(mL · h)], and bioavailability of these isoflavones is greater when ingested as ß-glycosides rather than aglycones as measured from the area under the curve of the plasma appearance and disappearance concentrations. The pharmacokinetics of methoxylated isoflavones show distinct differences depending on the position of the methoxyl group in the molecule. Glycitin, found in two phytoestrogen supplements, underwent hydrolysis of the ß-glycoside moiety and little further biotransformation, leading to high plasma glycitein concentrations. Biochanin A and formononetin, two isoflavones found in one phytoestrogen supplement, were rapidly and efficiently demethylated, resulting in high plasma genistein and daidzein concentrations typically observed after the ingestion of soy-containing foods. These differences in pharmacokinetics and metabolism have implications for clinical studies because it cannot be assumed that all isoflavones are comparable in their pharmacokinetics and bioavailability. An analysis of 33 phytoestrogen supplements and extracts revealed considerable differences in the isoflavone content from that claimed by the manufacturers. Plasma concentrations of isoflavones show marked qualitative and quantitative differences depending on the type of supplement ingested. These studies indicate a need for improvement in quality assurance and standardization of such products.
KEY WORDS: • phytoestrogens • isoflavones • pharmacokinetics • soy foods • supplements • humans • blood
This article has been cited by other articles:
|
|
 |
|
  K. D. Setchell, X. Zhao, P. Jha, J. E Heubi, and N. M Brown The pharmacokinetic behavior of the soy isoflavone metabolite S-(-)equol and its diastereoisomer R-(+)equol in healthy adults determined by using stable-isotope-labeled tracers Am. J. Clinical Nutrition, October 1, 2009; 90(4): 1029 - 1037. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. E. C. Hanwell, C. D. Kay, J. W. Lampe, B. J. Holub, and A. M. Duncan Acute Fish Oil and Soy Isoflavone Supplementation Increase Postprandial Serum (n-3) Polyunsaturated Fatty Acids and Isoflavones but Do Not Affect Triacylglycerols or Biomarkers of Oxidative Stress in Overweight and Obese Hypertriglyceridemic Men J. Nutr., June 1, 2009; 139(6): 1128 - 1134. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. WIEGAND, A. E. WAGNER, C. BOESCH-SAADATMANDI, H.-P. KRUSE, S. KULLING, and G. RIMBACH Effect of Dietary Genistein on Phase II and Antioxidant Enzymes in Rat Liver Cancer Genomics Proteomics, March 1, 2009; 6(2): 85 - 92. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. E. Gleason, C. M. Carlsson, J. H. Barnet, S. A. Meade, K. D. R. Setchell, C. S. Atwood, S. C. Johnson, M. L. Ries, and S. Asthana A preliminary study of the safety, feasibility and cognitive efficacy of soy isoflavone supplements in older men and women Age Ageing, January 1, 2009; 38(1): 86 - 93. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Hong, T. Wang, C. Huang, W. Cheng, and B. Lin Soy isoflavones supplementation alleviates disease severity in autoimmune-prone MRL-lpr/lpr mice Lupus, September 1, 2008; 17(9): 814 - 821. [Abstract] [PDF]
|
|
|
|
 |
|
 A. Orgaard and L. Jensen The Effects of Soy Isoflavones on Obesity Exp Biol Med, September 1, 2008; 233(9): 1066 - 1080. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. L. Hall, N. L. Formanuik, D. Harnpanich, M. Cheung, D. Talbot, P. J. Chowienczyk, and T. A. B. Sanders A Meal Enriched with Soy Isoflavones Increases Nitric Oxide-Mediated Vasodilation in Healthy Postmenopausal Women J. Nutr., July 1, 2008; 138(7): 1288 - 1292. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. E Rufer, A. Bub, J. Moseneder, P. Winterhalter, M. Sturtz, and S. E Kulling Pharmacokinetics of the soybean isoflavone daidzein in its aglycone and glucoside form: a randomized, double-blind, crossover study Am. J. Clinical Nutrition, May 1, 2008; 87(5): 1314 - 1323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nagarajan, R. L. Burris, B. W. Stewart, J. E. Wilkerson, and T. M. Badger Dietary Soy Protein Isolate Ameliorates Atherosclerotic Lesions in Apolipoprotein E-Deficient Mice Potentially by Inhibiting Monocyte Chemoattractant Protein-1 Expression J. Nutr., February 1, 2008; 138(2): 332 - 337. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Clerici, K. D. R. Setchell, P. M. Battezzati, M. Pirro, V. Giuliano, S. Asciutti, D. Castellani, E. Nardi, G. Sabatino, S. Orlandi, et al. Pasta Naturally Enriched with Isoflavone Aglycons from Soy Germ Reduces Serum Lipids and Improves Markers of Cardiovascular Risk J. Nutr., October 1, 2007; 137(10): 2270 - 2278. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Duffy, K. Perez, and A. Partridge Implications of Phytoestrogen Intake for Breast Cancer CA Cancer J Clin, September 1, 2007; 57(5): 260 - 277. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kottra and H. Daniel Flavonoid Glycosides Are Not Transported by the Human Na+/Glucose Transporter When Expressed in Xenopus laevis Oocytes, but Effectively Inhibit Electrogenic Glucose Uptake J. Pharmacol. Exp. Ther., August 1, 2007; 322(2): 829 - 835. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. R Walsh, S. J Haak, T. Bohn, Q. Tian, S. J Schwartz, and M. L Failla Isoflavonoid glucosides are deconjugated and absorbed in the small intestine of human subjects with ileostomies Am. J. Clinical Nutrition, April 1, 2007; 85(4): 1050 - 1056. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-A. Lee, W. Wen, Y.-B. Xiang, S. Barnes, D. Liu, Q. Cai, W. Zheng, and X. O. Shu Assessment of Dietary Isoflavone Intake among Middle-Aged Chinese Men J. Nutr., April 1, 2007; 137(4): 1011 - 1016. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. R. French, L. U. Thompson, and G. A. Hawker Validation of a Phytoestrogen Food Frequency Questionnaire with Urinary Concentrations of Isoflavones and Lignan Metabolites in Premenopausal Women J. Am. Coll. Nutr., February 1, 2007; 26(1): 76 - 82. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. K. Prasain, J. Xu, M. Kirk, M. Smith Johnson, J. Sfakianos, and S. Barnes Differential Biliary Excretion of Genistein Metabolites Following Intraduodenal and Intravenous Infusion of Genistin in Female Rats J. Nutr., December 1, 2006; 136(12): 2975 - 2979. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. W. J. Wang, J. Chen, X. Jia, V. H. Tam, and M. Hu Disposition of Flavonoids via Enteric Recycling: Structural Effects and Lack of Correlations between in Vitro and in Situ Metabolic Properties Drug Metab. Dispos., November 1, 2006; 34(11): 1837 - 1848. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Mezei, Y. Li, E. Mullen, J. S. Ross-Viola, and N. F. Shay Dietary isoflavone supplementation modulates lipid metabolism via PPAR{alpha}-dependent and -independent mechanisms Physiol Genomics, September 14, 2006; 26(1): 8 - 14. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Kano, T. Takayanagi, K. Harada, S. Sawada, and F. Ishikawa Bioavailability of Isoflavones after Ingestion of Soy Beverages in Healthy Adults J. Nutr., September 1, 2006; 136(9): 2291 - 2296. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Nagarajan, B. W. Stewart, and T. M. Badger Soy Isoflavones Attenuate Human Monocyte Adhesion to Endothelial Cell-Specific CD54 by Inhibiting Monocyte CD11a J. Nutr., September 1, 2006; 136(9): 2384 - 2390. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell and S. J. Cole Method of Defining Equol-Producer Status and Its Frequency among Vegetarians J. Nutr., August 1, 2006; 136(8): 2188 - 2193. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Gu, S. E. House, R. L. Prior, N. Fang, M. J. J. Ronis, T. B. Clarkson, M. E. Wilson, and T. M. Badger Metabolic Phenotype of Isoflavones Differ among Female Rats, Pigs, Monkeys, and Women J. Nutr., May 1, 2006; 136(5): 1215 - 1221. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. H. Ju, J. Fultz, K. F. Allred, D. R. Doerge, and W. G. Helferich Effects of dietary daidzein and its metabolite, equol, at physiological concentrations on the growth of estrogen-dependent human breast cancer (MCF-7) tumors implanted in ovariectomized athymic mice Carcinogenesis, April 1, 2006; 27(4): 856 - 863. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Nakajima, M. Itoh, H. Yamanaka, T. Fukami, S. Tokudome, Y. Yamamoto, H. Yamamoto, and T. Yokoi Isoflavones Inhibit Nicotine C-Oxidation Catalyzed by Human CYP2A6. J. Clin. Pharmacol., March 1, 2006; 46(3): 337 - 344. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Cassidy, J. E. Brown, A. Hawdon, M. S. Faughnan, L. J. King, J. Millward, L. Zimmer-Nechemias, B. Wolfe, and K. D.R. Setchell Factors Affecting the Bioavailability of Soy Isoflavones in Humans after Ingestion of Physiologically Relevant Levels from Different Soy Foods J. Nutr., January 1, 2006; 136(1): 45 - 51. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, S. Wang, X. Jia, S. Bajimaya, H. Lin, V. H. Tam, and M. Hu DISPOSITION OF FLAVONOIDS VIA RECYCLING: COMPARISON OF INTESTINAL VERSUS HEPATIC DISPOSITION Drug Metab. Dispos., December 1, 2005; 33(12): 1777 - 1784. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. S. Green, T. R. Foss, and J. W. Kelly Genistein, a natural product from soy, is a potent inhibitor of transthyretin amyloidosis PNAS, October 11, 2005; 102(41): 14545 - 14550. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Svechnikov, V Supornsilchai, M-L Strand, A Wahlgren, D Seidlova-Wuttke, W Wuttke, and O Soder Influence of long-term dietary administration of procymidone, a fungicide with anti-androgenic effects, or the phytoestrogen genistein to rats on the pituitary-gonadal axis and Leydig cell steroidogenesis J. Endocrinol., October 1, 2005; 187(1): 117 - 124. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. R Kessenich Review: plant based oestrogens do not relieve hot flushes or other menopausal symptoms Evid. Based Nurs., July 1, 2005; 8(3): 83 - 83. [Full Text] [PDF]
|
|
|
|
 |
|
 M. I. Genovese, N. M.A. Hassimotto, and F. M. Lajolo Isoflavone Profile and Antioxidant Activity of Brazilian Soybean Varieties Food Science and Technology International, June 1, 2005; 11(3): 205 - 211. [Abstract] [PDF]
|
|
|
|
|
|
E. J. Jeong, Y. Liu, H. Lin, and M. Hu SPECIES- AND DISPOSITION MODEL-DEPENDENT METABOLISM OF RALOXIFENE IN GUT AND LIVER: ROLE OF UGT1A10 Drug Metab. Dispos., June 1, 2005; 33(6): 785 - 794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. E. Hedlund, P. D. Maroni, P. G. Ferucci, R. Dayton, S. Barnes, K. Jones, R. Moore, L. G. Ogden, K. Wahala, H. M. Sackett, et al. Long-Term Dietary Habits Affect Soy Isoflavone Metabolism and Accumulation in Prostatic Fluid in Caucasian Men J. Nutr., June 1, 2005; 135(6): 1400 - 1406. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, C. Clerici, E. D Lephart, S. J Cole, C. Heenan, D. Castellani, B. E Wolfe, L. Nechemias-Zimmer, N. M Brown, T. D Lund, et al. S-Equol, a potent ligand for estrogen receptor {beta}, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora Am. J. Clinical Nutrition, May 1, 2005; 81(5): 1072 - 1079. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, G. Williamson, C. Morand, A. Scalbert, and C. Remesy Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 230S - 242S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Williamson and C. Manach Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies Am. J. Clinical Nutrition, January 1, 2005; 81(1): 243S - 255S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Zheng, S.-O. Lee, M. A. Verbruggen, P. A. Murphy, and S. Hendrich The Apparent Absorptions of Isoflavone Glucosides and Aglucons Are Similar in Women and Are Increased by Rapid Gut Transit Time and Low Fecal Isoflavone Degradation J. Nutr., October 1, 2004; 134(10): 2534 - 2539. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
X. Jia, J. Chen, H. Lin, and M. Hu Disposition of Flavonoids via Enteric Recycling: Enzyme-Transporter Coupling Affects Metabolism of Biochanin A and Formononetin and Excretion of Their Phase II Conjugates J. Pharmacol. Exp. Ther., September 1, 2004; 310(3): 1103 - 1113. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. E Fugate and C. O Church Nonestrogen Treatment Modalities for Vasomotor Symptoms Associated with Menopause Ann. Pharmacother., September 1, 2004; 38(9): 1482 - 1499. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. A. Nettleton, K. A. Greany, W. Thomas, K. E. Wangen, H. Adlercreutz, and M. S. Kurzer Plasma Phytoestrogens Are Not Altered by Probiotic Consumption in Postmenopausal Women with and without a History of Breast Cancer J. Nutr., August 1, 2004; 134(8): 1998 - 2003. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, W. Oosthuizen, S. Scollen, A. Loktionov, N. E. Day, and S. A. Bingham Modest Protective Effects of Isoflavones from a Red Clover-Derived Dietary Supplement on Cardiovascular Disease Risk Factors in Perimenopausal Women, and Evidence of an Interaction with ApoE Genotype in 49-65 Year-Old Women J. Nutr., July 1, 2004; 134(7): 1759 - 1764. [Abstract] [Full Text]
|
|
|
|
|
|
A.-C. Chen and S. M. Donovan Genistein at a Concentration Present in Soy Infant Formula Inhibits Caco-2BBe Cell Proliferation by Causing G2/M Cell Cycle Arrest J. Nutr., June 1, 2004; 134(6): 1303 - 1308. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Manach, A. Scalbert, C. Morand, C. Remesy, and L. Jimenez Polyphenols: food sources and bioavailability Am. J. Clinical Nutrition, May 1, 2004; 79(5): 727 - 747. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. W. Erdman Jr., T. M. Badger, J. W. Lampe, K. D.R. Setchell, and M. Messina Not All Soy Products Are Created Equal: Caution Needed in Interpretation of Research Results J. Nutr., May 1, 2004; 134(5): 1229S - 1233S. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, J. E Compston, N. E Day, M. Dowsett, and S. A Bingham The effects of phytoestrogen isoflavones on bone density in women: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, February 1, 2004; 79(2): 326 - 333. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. M. Cline, A. A. Franke, T. C. Register, D. L. Golden, and M. R. Adams Effects of Dietary Isoflavone Aglycones on the Reproductive Tract of Male and Female Mice Toxicol Pathol, January 1, 2004; 32(1): 91 - 99. [Abstract] [PDF]
|
|
|
|
 |
|
 J. D. Wagner, D. C. Schwenke, K. A. Greaves, L. Zhang, M. S. Anthony, R. M. Blair, M. K. Shadoan, and J. K. Williams Soy Protein With Isoflavones, but not an Isoflavone-Rich Supplement, Improves Arterial Low-Density Lipoprotein Metabolism and Atherogenesis Arterioscler Thromb Vasc Biol, December 1, 2003; 23(12): 2241 - 2246. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Fanti, T. J. Stephenson, I. M. Kaariainen, B. Rezkalla, Y. Tsukamoto, T. Morishita, M. Nomura, C. Kitiyakara, L. J. Custer, and A. A. Franke Serum isoflavones and soya food intake in Japanese, Thai and American end-stage renal disease patients on chronic haemodialysis Nephrol. Dial. Transplant., September 1, 2003; 18(9): 1862 - 1868. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. A. Tice, B. Ettinger, K. Ensrud, R. Wallace, T. Blackwell, and S. R. Cummings Phytoestrogen Supplements for the Treatment of Hot Flashes: The Isoflavone Clover Extract (ICE) Study: A Randomized Controlled Trial JAMA, July 9, 2003; 290(2): 207 - 214. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Hu, K. Krausz, J. Chen, X. Ge, J. Li, H. L. Gelboin, and Frank. J. Gonzalez IDENTIFICATION OF CYP1A2 AS THE MAIN ISOFORM FOR THE PHASE I HYDROXYLATED METABOLISM OF GENISTEIN AND A PRODRUG CONVERTING ENZYME OF METHYLATED ISOFLAVONES Drug Metab. Dispos., July 1, 2003; 31(7): 924 - 931. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Zubik and M. Meydani Bioavailability of soybean isoflavones from aglycone and glucoside forms in American women Am. J. Clinical Nutrition, June 1, 2003; 77(6): 1459 - 1465. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. J. Teede, B. P. McGrath, L. DeSilva, M. Cehun, A. Fassoulakis, and P. J. Nestel Isoflavones Reduce Arterial Stiffness: A Placebo-Controlled Study in Men and Postmenopausal Women Arterioscler Thromb Vasc Biol, June 1, 2003; 23(6): 1066 - 1071. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Mezei, W. J. Banz, R. W. Steger, M. R. Peluso, T. A. Winters, and N. Shay Soy Isoflavones Exert Antidiabetic and Hypolipidemic Effects through the PPAR Pathways in Obese Zucker Rats and Murine RAW 264.7 Cells J. Nutr., May 1, 2003; 133(5): 1238 - 1243. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, P. B. Desai, L. Zimmer-Nechimias, B. Wolfe, A. S. Jakate, V. Creutzinger, and J. E. Heubi Bioavailability, Disposition, and Dose-Response Effects of Soy Isoflavones When Consumed by Healthy Women at Physiologically Typical Dietary Intakes J. Nutr., April 1, 2003; 133(4): 1027 - 1035. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Liew, J. K. Williams, P. Collins, and K. T. MacLeod Soy-Derived Isoflavones Exert Opposing Actions on Guinea Pig Ventricular Myocytes J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 985 - 993. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Chen, H. Lin, and M. Hu Metabolism of Flavonoids via Enteric Recycling: Role of Intestinal Disposition J. Pharmacol. Exp. Ther., March 1, 2003; 304(3): 1228 - 1235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, M. S Faughnan, T. Avades, L. Zimmer-Nechemias, N. M Brown, B. E Wolfe, W. T Brashear, P. Desai, M. F Oldfield, N. P Botting, et al. Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women Am. J. Clinical Nutrition, February 1, 2003; 77(2): 411 - 419. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell, N. M. Brown, and E. Lydeking-Olsen The Clinical Importance of the Metabolite Equol--A Clue to the Effectiveness of Soy and Its Isoflavones J. Nutr., December 1, 2002; 132(12): 3577 - 3584. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. M. Blair, S. E. Appt, C. Bennetau-Pelissero, T. B. Clarkson, M. S. Anthony, V. Lamothe, and S. M. Potter Dietary Soy and Soy Isoflavones Have Gender-Specific Effects on Plasma Lipids and Isoflavones in Golden Syrian F1B Hybrid Hamsters J. Nutr., December 1, 2002; 132(12): 3585 - 3591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Adams, D. L. Golden, T. C. Register, M. S. Anthony, J. B. Hodgin, N. Maeda, and J.K. Williams The Atheroprotective Effect of Dietary Soy Isoflavones in Apolipoprotein E-/- Mice Requires the Presence of Estrogen Receptor-{alpha} Arterioscler Thromb Vasc Biol, November 1, 2002; 22(11): 1859 - 1864. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Richelle, S. Pridmore-Merten, S. Bodenstab, M. Enslen, and E. A. Offord Hydrolysis of Isoflavone Glycosides to Aglycones by {beta}-Glycosidase Does Not Alter Plasma and Urine Isoflavone Pharmacokinetics in Postmenopausal Women J. Nutr., September 1, 2002; 132(9): 2587 - 2592. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. Setchell, N. M Brown, L. Zimmer-Nechemias, W. T Brashear, B. E Wolfe, A. S Kirschner, and J. E Heubi Evidence for lack of absorption of soy isoflavone glycosides in humans, supporting the crucial role of intestinal metabolism for bioavailability Am. J. Clinical Nutrition, August 1, 2002; 76(2): 447 - 453. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. Tsunoda, S. Pomeroy, and P. Nestel Absorption in Humans of Isoflavones from Soy and Red Clover Is Similar J. Nutr., August 1, 2002; 132(8): 2199 - 2201. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. Murota, S. Shimizu, S. Miyamoto, T. Izumi, A. Obata, M. Kikuchi, and J. Terao Unique Uptake and Transport of Isoflavone Aglycones by Human Intestinal Caco-2 Cells: Comparison of Isoflavonoids and Flavonoids J. Nutr., July 1, 2002; 132(7): 1956 - 1961. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. Yellayi, A. Naaz, M. A. Szewczykowski, T. Sato, J. A. Woods, J. Chang, M. Segre, C. D. Allred, W. G. Helferich, and P. S. Cooke The phytoestrogen genistein induces thymic and immune changes: A human health concern? PNAS, May 28, 2002; 99(11): 7616 - 7621. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu and M. Hu Absorption and Metabolism of Flavonoids in the Caco-2 Cell Culture Model and a Perused Rat Intestinal Model Drug Metab. Dispos., April 1, 2002; 30(4): 370 - 377. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. A. Lamartiniere, J. Wang, M. Smith-Johnson, and I.-E. Eltoum Daidzein: Bioavailability, Potential for Reproductive Toxicity, and Breast Cancer Chemoprevention in Female Rats Toxicol. Sci., February 1, 2002; 65(2): 228 - 238. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Adams, D. L. Golden, M. S. Anthony, T. C. Register, and J. K. Williams The Inhibitory Effect of Soy Protein Isolate on Atherosclerosis in Mice Does Not Require the Presence of LDL Receptors or Alteration of Plasma Lipoproteins J. Nutr., January 1, 2002; 132(1): 43 - 49. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. H. Ju, C. D. Allred, K. F. Allred, K. L. Karko, D. R. Doerge, and W. G. Helferich Physiological Concentrations of Dietary Genistein Dose-Dependently Stimulate Growth of Estrogen-Dependent Human Breast Cancer (MCF-7) Tumors Implanted in Athymic Nude Mice J. Nutr., November 1, 2001; 131(11): 2957 - 2962. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. J. Messina and C. L. Loprinzi Soy for Breast Cancer Survivors: A Critical Review of the Literature J. Nutr., November 1, 2001; 131(11): 3095S - 3108. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K. D. R. Setchell Soy Isoflavones--Benefits and Risks from Nature's Selective Estrogen Receptor Modulators (SERMs) J. Am. Coll. Nutr., October 1, 2001; 20(90005): 354S - 362. [Abstract] [Full Text]
|
|
